Indoco Remedies Limited has informed the Exchange regarding a press release dated August 13, 2025, titled "Indoco Remedies receives final ANDA approval from USFDA forRivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg".
Indoco Remedies Limited has informed the Exchange regarding a press release dated August 13, 2025, titled "Indoco Remedies receives final ANDA approval from USFDA forRivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg".